Animal experiment showed that the co-delivered anti-miR-21 and miR-124 simultaneously regulated the mutant RAS/PI3K/PTEN/AKT signaling pathway in GBM cells, and a robust therapeutic effect was obtained. The gene discussed is PTEN; the disease is glioblastoma.